15th Annual CHFR Symposium on Heart Failure

September 20-22 2017 at Holmenkollen Park Hotel, Oslo, Norway.

Click for more information and registration...

Key note by Calum A. MacRae, Brigham and Women’s Hospital and Harvard Medical School. Other confirmed speakers:
Anthony Rosenzweig, Harvard Medical School, USA.
Burkert Pieske, Charité Universitätsmedizin Berlin and Deutsches Herzzentrum Berlin.
Carolyn Lam, National Heart Centre Singapore.
Dan Roden, Vanderbilt University Medical Center, USA.
James L Januzzi, Massachusetts General Hospital and Harvard Research Clinical Institute, USA.
Julia Gorelik, Imperial College London, UK.
Leon Axel, NYU Langhorne Medical Center, USA
Ole M. Sejersted, University of Oslo and Oslo University Hospital
Peter Libby, Brigham and Women's Hospital, Harvard Med. School, USA.
Stefan Engelhardt, Technische Universität München.
Sumanth D. Prabhu, University of Alabama, USA.
Victoria Delgado, Leiden University Medical Center, The Netherlands.

Norwegian Society of Cardiology LOGO

Review of the 14th Annual CHFR Symposium

A Review of the 14th Annual CHFR Symposium on heart failure is published in the Journal of the Norwegian Society of Cardiology
"Hjerteforum 4 - 2016".

Read the article (in Norwegian) by Erik Øie.

Journal of Biological Chemistry 2016

Hot Topics: Protein phosphatase 1c associated with the cardiac sodium calcium exchanger 1 (NCX1) regulates its activity by dephosphorylating serine 68-phosphorylated phospholemman

NCX1, an important regulator of intracellular Ca2+ homeostasis, is a substrate-specifying PP1c-targeting protein. Using a variety of molecular techniques, this study demonstrates that cardiac NCX1 facilitating its own regulation by mediating dephosphorylation of pSer-68-phospholemman.

Read more in Journal of Biological Chemistry

Resuscitation 2016

Hot Topics: NT-proBNP levels improve risk assessment for poor outcome in patients with out-of-hospital cardiac arrest

NT-proBNP levels measured 24 hrs after out-of-hospital cardiac arrest predicted mortality and poor neurological outcome after one year on top of established risk indices.

Read more in Resuscitation

European Heart Journal 2016

Hot Topics: Tocilizumab attenuated the inflammatory response and primarily PCI-related TnT release in NSTEMI patients

In a double-blind, placebo-controlled trial including 117 patients with NSTEMI, the IL-6 receptor antagonist tocilizumab administered as a single dose prior to coronary angiography reduced the levels of CRP and troponin-T.

Read more in European Heart Journal

QuoteIllustrasjon forside

The Norwegian PhD School of Heart Research (NORHEART) is a collaborating partner. Please see www.norheart.no

Click to Apply for membership

Recent publications

Read abstracts from our publications here

Med en doktor i magen

I gang med innlevering av doktorgrad? Les "Med en doktor i magen"

Se også Forskningshåndboken - et verktøy for alle som driver med medisinsk og helsefaglig forskning.


Webmaster Vidar, IEMF